NCT04876586

Brief Summary

The aim of the present study is to find out whether fusion of a sinlge level SPECT/CT positive degenerative disc disease leads to a significant improvement of pain and disability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

May 3, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 6, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

June 26, 2023

Status Verified

June 1, 2023

Enrollment Period

4 years

First QC Date

May 3, 2021

Last Update Submit

June 22, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Improvement in Oswestry Disability Index (ODI)

    The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire. The self-completed questionnaire contains ten topics concerning intensity of pain, lifting, ability to care for oneself, ability to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to travel. he scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 10). Zero is equated with no disability and 10 is the maximum disability possible.

    2 years

  • Improvement in Pain Visual Analogue Scale (VAS)

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between VAS 0 (no pain) and VAS 10 (worst pain).

    2 years

Interventions

Lumbar fusionPROCEDURE

Transforaminal Lumbar Interbody Fusion of the SPECT/CT positive degenerative disc disease

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

An open prospective cohort study will be performed. Inclusion criteria will be: subjects between 18 and 75 years of age; both genders; with CBP and diagnosis of DDD or facet arthropathy on MRI and increased metabolic activity on bone SPECT/CT imaging in the same level(s) who are undergoing open lumbar interbody fusion. New MRI of the lumbar spine and SPECT/CT will be performed 2 years after the surgical procedure. The patients will complete ODI and VAS questionnaires before surgery and at 6- and 24-months follow-up visits. All patients will sign an informed consent form.

You may qualify if:

  • Lower back pain (in extension +/- pain in buttocks, groin, thigh) without radicular pain
  • Symptoms \> 6 months after failure of conservative management in the primary care setting
  • MRI signs of degenerative disc disease or facet arthropathy
  • One-level positivity on lumbar SPECT/CT

You may not qualify if:

  • Other spinal pathology (tumours, congenital defects, spondylolysis or spondylolisthesis)
  • Intolerance of SPECT examination
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Military University Hospital Prague

Prague, 16902, Czechia

Location

University Hospital, Motol

Prague, Czechia

Location

Related Publications (1)

  • Kaiser R, Varga M, Lang O, Waldauf P, Vanek P, Saur K, Benes V, Netuka D. Spinal fusion for single-level SPECT/CT positive lumbar degenerative disc disease: the SPINUS I study. Acta Neurochir (Wien). 2023 Sep;165(9):2633-2640. doi: 10.1007/s00701-023-05666-8. Epub 2023 Jun 22.

Related Links

MeSH Terms

Conditions

Intervertebral Disc DegenerationLow Back Pain

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesBack PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jaroslav Plas

    Military University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Radek Kaiser, MD, PhD

Study Record Dates

First Submitted

May 3, 2021

First Posted

May 6, 2021

Study Start

January 1, 2018

Primary Completion

January 1, 2022

Study Completion

February 1, 2023

Last Updated

June 26, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations